Acetato de eslicarbazepina Pharmakern 800 mg Comprimido

Država: Portugal

Jezik: portugalski

Izvor: INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

Kupi sada

Uputa o lijeku Uputa o lijeku (PIL)
15-01-2020
Svojstava lijeka Svojstava lijeka (SPC)
22-05-2024

Aktivni sastojci:

Acetato de eslicarbazepina

Dostupno od:

Pharmakern Portugal - Produtos Farmacêuticos, Sociedade Unipessoal, Lda.

ATC koda:

N03AF04

INN (International ime):

Acetate eslicarbazepina

Doziranje:

800 mg

Farmaceutski oblik:

Comprimido

Sastav:

Acetato de eslicarbazepina 800 mg

Administracija rute:

Via oral

Jedinice u paketu:

Blister 20 unidade(s)

Razred:

2.6 - Antiepilépticos e anticonvulsivantes

Tip recepta:

MSRM

Terapijska grupa:

Genérico

Područje terapije:

eslicarbazepine

Terapijske indikacije:

Duração do Tratamento: Longa Duração

Proizvod sažetak:

Número de Registo: 5788708 CNPEM: 50117254 CHNM: 10097542 Não Comercializado

Status autorizacije:

Autorizado

Datum autorizacije:

2020-01-15

Uputa o lijeku

                                $3529$'2(0

,1)$50('


)ROKHWRLQIRUPDWLYR,QIRUPD©¥RSDUDRXWLOL]DGRU
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQPJFRPSULPLGRV
$FHWDWRGHHVOLFDUED]HSLQD
/HLDFRPDWHQ©¥RWRGRHVWHIROKHWRDQWHVGHFRPH©DUDWRPDURXGDUHVWHPHGLFDPHQWR
¢VXDFULDQ©DSRLVFRQW«PLQIRUPD©¥RLPSRUWDQWHSDUDVL
&RQVHUYHHVWHIROKHWR3RGHWHUQHFHVVLGDGHGHROHUQRYDPHQWH
&DVRDLQGDWHQKDG¼YLGDVIDOHFRPRVHXP«GLFRRXIDUPDF¬XWLFR
(VWHPHGLFDPHQWRIRLUHFHLWDGRDSHQDVSDUDVL1¥RGHYHG£ORDRXWURV2
PHGLFDPHQWRSRGHVHUOKHVSUHMXGLFLDOPHVPRTXHDSUHVHQWHPRVPHVPRVVLQDLVGH
GRHQ©D
6HWLYHUTXDLVTXHUHIHLWRVLQGHVHM£YHLVLQFOXLQGRSRVV¯YHLVHIHLWRVLQGHVHM£YHLVQ¥R
LQGLFDGRVQHVWHIROKHWRIDOHFRPRVHXP«GLFRRXIDUPDF¬XWLFR

2TXHFRQW«PHVWHIROKHWR
2TXH«$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQHSDUDTXH«XWLOL]DGR
2TXHSUHFLVDGHVDEHUDQWHVGHWRPDU$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ
&RPRWRPDU$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ
(IHLWRVLQGHVHM£YHLVSRVV¯YHLV
&RPRFRQVHUYDU$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ
&RQWH¼GRGDHPEDODJHPHRXWUDVLQIRUPD©·HV
$3529$'2(0

,1)$50('



2TXH«$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQHSDUDTXH«XWLOL]DGR
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQFRQW«PDVXEVW¤QFLDDWLYDDFHWDWRGH
HVOLFDUED]HSLQD
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQSHUWHQFHDXPJUXSRGHPHGLFDPHQWRV
FKDPDGRVDQWLHSLO«WLFRVH«XVDGRSDUDWUDWDUDHSLOHSVLDXPDGRHQ©DTXHVHPDQLIHVWD
SRUFRQYXOV·HVRXFULVHVHSLO«WLFDVUHSHWLGDV
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ«XVDGR
LVRODGDPHQWHPRQRWHUDSLDQRWUDWDPHQWRGHGRHQWHVDGXOWRVFRPHSLOHSVLD
UHFHQWHPHQWHGLDJQRVWLFDGD
HPFRQMXQWRFRPRXWURVPHGLFDPHQWRVDQWLHSLO«WLFRVWHUDS¬XWLFDDGMXYDQWHQR
WUDWDPHQWRGHGRHQWHVDGXOWRVDGROHVFHQWHVHFULDQ©DVFRPPDLVGHDQRVW¬PFULVHV
TXHDIHWDPXPDSDUWHGRF«UHEURFULVHVSDUFLDLV(VWDVFULVHVSRGHPVHUVHJXLGDVRX
Q¥RGHXPDFULVHTXHDIHWDWRGRR
                                
                                Pročitajte cijeli dokument
                                
                            

Svojstava lijeka

                                $3529$'2(0

,1)$50('


5(6802'$6&$5$&7(567,&$6'20(',&$0(172
120('20(',&$0(172
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQPJFRPSULPLGRV
&20326,‰…248$/,7$7,9$(48$17,7$7,9$
&DGDFRPSULPLGRFRQW«PPJGHDFHWDWRGHHVOLFDUED]HSLQD
([FLSLHQWHFRPHIHLWRFRQKHFLGR
6µGLRVREDIRUPDGHFURVFDUPHORVHVµGLFDPJSRUFRPSULPLGR
/LVWDFRPSOHWDGHH[FLSLHQWHVYHUVHF©¥R
)250$)$50$&Œ87,&$
&RPSULPLGR
&RPSULPLGRVEUDQFRVREORQJRVELFRQYH[RVHFRPXPDUDQKXUDHPDPERVRVODGRV
FRPFRPSULPHQWRGHPP2FRPSULPLGRSRGHVHUGLYLGLGRHPGRVHVLJXDLV
,1)250$‰—(6&/1,&$6
,QGLFD©·HVWHUDS¬XWLFDV
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ«LQGLFDGR
FRPRPRQRWHUDSLDQRWUDWDPHQWRGHFULVHVHSLO«WLFDVSDUFLDLVFRPRXVHP
JHQHUDOL]D©¥RVHFXQG£ULDHPGRHQWHVDGXOWRVFRPHSLOHSVLDUHFHQWHPHQWH
GLDJQRVWLFDGD
FRPRWHUDS¬XWLFDDGMXYDQWHHPGRHQWHVDGXOWRVDGROHVFHQWHVHFULDQ©DVFRPPDLVGH
DQRVGHLGDGHFRPFULVHVHSLO«WLFDVSDUFLDLVFRPRXVHPJHQHUDOL]D©¥RVHFXQG£ULD
$3529$'2(0

,1)$50('


3RVRORJLDHPRGRGHDGPLQLVWUD©¥R
3RVRORJLD
$GXOWRV
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQSRGHVHUWRPDGRFRPRPRQRWHUDSLDRXVHU
DGLFLRQDGRDXPDWHUDS¬XWLFDDQWLFRQYXOVLYDQWHH[LVWHQWH$GRVHLQLFLDOUHFRPHQGDGD«
GHPJXPDYH]SRUGLDTXHGHYHVHUDXPHQWDGDSDUD
PJXPDYH]SRUGLDDSµVXPDRXGXDVVHPDQDV'HSHQGHQGRGDUHVSRVWD
LQGLYLGXDOGHFDGDGRHQWHHVWDGRVHSRGHVHUDXPHQWDGDSDUDPJXPDYH]SRU
GLD$OJXQVGRHQWHVHPUHJLPHGHPRQRWHUDSLDSRGHU¥REHQHILFLDUGHXPDGRVHGH
PJXPDYH]SRUGLDYHUVHF©¥R
3RSXOD©·HVHVSHFLDLV
,GRVRVFRPPDLVGHDQRVGHLGDGH
1¥R«QHFHVV£ULRDMXVWHGHGRVHQDSRSXOD©¥RLGRVDGHVGHTXHDIXQ©¥RUHQDOQ¥R
HVWHMDFRPSURPHWLGD'HYLGR¢H[LVW¬QFLDGHGDGRVPXLWROLPLWDGRVVREUHRUHJLPHGH
PRQRWHUDSLDFRPPJHPLGRVRVHVWDGRVHQ¥RHVW£UHFRPHQGDGDSDUDHVWD
SRSXOD©¥R
&RPSURPLVVRUHQDO
5HFR
                                
                                Pročitajte cijeli dokument
                                
                            

Upozorenja za pretraživanje vezana za ovaj proizvod